HLA-B
HLA class I histocompatibility antigen, B alpha chain
Also known as: AS, HLAB_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01889
- Gene
- HLA-B
- Ensembl
- ENSG00000234745
- Chromosome
- 6
- Canonical length
- 362 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins
- Quaternary structure
- Homodimer
OverviewNCBI Gene
HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
362 residues, UniProt reviewed canonical sequence.
>P01889|HLA-B
1 MLVMAPRTVL LLLSAALALT ETWAGSHSMR YFYTSVSRPG RGEPRFISVG YVDDTQFVRF
61 DSDAASPREE PRAPWIEQEG PEYWDRNTQI YKAQAQTDRE SLRNLRGYYN QSEAGSHTLQ
121 SMYGCDVGPD GRLLRGHDQY AYDGKDYIAL NEDLRSWTAA DTAAQITQRK WEAAREAEQR
181 RAYLEGECVE WLRRYLENGK DKLERADPPK THVTHHPISD HEATLRCWAL GFYPAEITLT
241 WQRDGEDQTQ DTELVETRPA GDRTFQKWAA VVVPSGEEQR YTCHVQHEGL PKPLTLRWEP
301 SSQSTVPIVG IVAGLAVLAV VVIGAVVAAV MCRRKSSGGK GGSYSQAACS DSAQGSDVSL
361 TALocalizationUniProt · AlphaFold · HPA
Whether an antibody against HLA-B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 2,350 nTPM
Expression across tissuesHPA
Tissue
- spleen: 2,350 nTPM
- lung: 1,567 nTPM
- small intestine: 1,217 nTPM
- lymph node: 980 nTPM
- adipose tissue: 906 nTPM
- skin: 883 nTPM
Single-cell type
- platelets: 302 nCPM
- neutrophils: 267 nCPM
- nk-cells: 210 nCPM
- endometrial secretory cells: 194 nCPM
- t-cells: 192 nCPM
- plasma cells: 178 nCPM
Immune cell
- neutrophil: 414 nTPM
- total PBMC: 389 nTPM
- gdT-cell: 229 nTPM
- eosinophil: 227 nTPM
- MAIT T-cell: 211 nTPM
- naive CD8 T-cell: 208 nTPM
Brain region
- midbrain: 15 nTPM
- medulla oblongata: 10 nTPM
- cerebral cortex: 10 nTPM
- hypothalamus: 7.5 nTPM
- pons: 7.3 nTPM
- thalamus: 6.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about HLA-B.
Disease | AllUniProt
Conditions HLA-B is implicated in, by any mechanism.
- Stevens-Johnson syndrome (SJS) MIM:608579
- Spondyloarthropathy 1 (SPDA1) MIM:106300
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 115 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Disease | ImmuneIEDB
Conditions an epitope on HLA-B was assayed in.
- autoimmune uveitis T cell
- type 1 diabetes mellitus T cell
- viral infectious disease T cell
- ankylosing spondylitis T cell
- rheumatoid arthritis T cell
- Behcet's disease T cell
- Lyme disease T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.91
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.01
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- selective
OntologyGO
Biological processes
- adaptive immune response
- antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent
- antigen processing and presentation of endogenous peptide antigen via MHC class Ib
- defense response
- detection of bacterium
- immune response
- innate immune response
- positive regulation of T cell mediated cytotoxicity
- protection from natural killer cell mediated cytotoxicity
- regulation of dendritic cell differentiation
- regulation of interleukin-12 production
- regulation of interleukin-6 production
- regulation of T cell anergy
Molecular functions
Cellular components
- cell surface
- early endosome membrane
- endoplasmic reticulum
- ER to Golgi transport vesicle membrane
- external side of plasma membrane
- extracellular exosome
- extracellular space
- Golgi apparatus
- Golgi membrane
- lumenal side of endoplasmic reticulum membrane
- membrane
- MHC class I protein complex
- phagocytic vesicle membrane
- plasma membrane
- recycling endosome membrane
- secretory granule membrane
Protein domainsUniProt · Pfam · InterPro
- MHC class I alpha chain, alpha1 alpha2 domains
- Immunoglobulin/major histocompatibility complex, conserved site
- Immunoglobulin C1-set
- Immunoglobulin-like domain
- MHC class I, alpha chain, C-terminal
- MHC class I-like antigen recognition-like
- MHC classes I/II-like antigen recognition protein
- Immunoglobulin-like fold
- Immunoglobulin-like domain superfamily
- MHC class I-like antigen recognition-like superfamily
- Antigen-presenting and immune regulatory MHC class I-related
- Class I Histocompatibility antigen, domains alpha 1 and 2
- MHC_I C-terminus
- Immunoglobulin C1-set domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HLA-B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HLA-B as an antibody target. Whether an autoantibody or antibody against HLA-B could matter depends on whether native HLA-B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HLA-B is annotated at the cell surface, where native HLA-B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label HLA-B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...